These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28360822)

  • 1. Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study.
    Gerotziafas GT; Van Dreden P; Mathieu d'Argent E; Lefkou E; Grusse M; Comtet M; Sangare R; Ketatni H; Larsen AK; Elalamy I
    Thromb J; 2017; 15():9. PubMed ID: 28360822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
    Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
    Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study.
    Gerotziafas GT; Zografos T; Pantos I; Lefkou E; Carlo A; Fareed J; Van Dreden P; Katritsis D
    Clin Appl Thromb Hemost; 2020; 26():1076029620964590. PubMed ID: 33284037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
    Fotiou D; Sergentanis TN; Papageorgiou L; Stamatelopoulos K; Gavriatopoulou M; Kastritis E; Psaltopoulou T; Salta S; Van Dreden P; Sangare R; Larsen AK; Terpos E; Elalamy I; Dimopoulos MA; Gerotziafas GT
    Blood Cancer J; 2018 Nov; 8(11):102. PubMed ID: 30405097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.
    Chaari M; Ayadi I; Rousseau A; Lefkou E; Van Dreden P; Sidibe F; Ketatni H; Galea V; Khaterchi A; Bouzguenda R; Frikha M; Ghorbal L; Daoud J; Kallel C; Quinn M; Gligorov J; Lotz JP; Hatmi M; Elalamy I; Gerotziafas GT
    BMC Cancer; 2014 Dec; 14():991. PubMed ID: 25535397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
    Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
    Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy.
    Balandina AN; Koltsova EM; Teterina TA; Yakovenko AG; Simonenko EU; Poletaev AV; Zorina IV; Shibeko AM; Vuimo TA; Yakovenko SA; Ataullakhanov FI
    PLoS One; 2019; 14(5):e0216724. PubMed ID: 31120933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure.
    Van Dreden P; Woodhams B; Rousseau A; Dreyfus JF; Vasse M
    Clin Chem Lab Med; 2013 Feb; 51(2):387-96. PubMed ID: 23096108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study.
    Boura P; Evmorfiadis I; Rousseau A; Charpidou A; Giozos G; Van Dreden P; Syrigos K; Larsen A; Elalamy I; Gerotziafas GT
    Thromb Res; 2016 Apr; 140 Suppl 1():S196. PubMed ID: 27161741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study.
    Lentschener C; Flaujac C; Ibrahim F; Gouin-Thibault I; Bazin M; Sogni P; Samama CM
    Eur J Anaesthesiol; 2016 Feb; 33(2):126-33. PubMed ID: 26258657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of endometrial and subendometrial vasculature on the day of embryo transfer and prediction of pregnancy during fresh in vitro fertilization cycles.
    Kim A; Jung H; Choi WJ; Hong SN; Kim HY
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):360-5. PubMed ID: 25286791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis.
    Tamura H; Yoshida H; Kikuchi H; Josaki M; Mihara Y; Shirafuta Y; Shinagawa M; Tamura I; Taketani T; Takasaki A; Sugino N
    J Ovarian Res; 2019 Dec; 12(1):123. PubMed ID: 31831028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study.
    Mendoza-Tesarik R; Mendoza N; López CC; Tesarik J
    Reprod Biomed Online; 2019 Aug; 39(2):225-230. PubMed ID: 31178369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.
    Szanto T; Nummi V; Jouppila A; Brinkman HJM; Lassila R
    Platelets; 2020; 31(1):103-111. PubMed ID: 30836803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
    Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
    Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.